Dr. Sanket Mehta’s clinic, which is located at Charni Road Station in Mumbai, India, specialises in hyperthermic intra-peritoneal chemotherapy (HIPEC), an innovative chemotherapy treatment that targets remaining cancer cells following the surgical removal of tumours. Dr. Mehta is the first surgeon in India to treat peritoneal malignancies with HIPEC and cytoreductive surgery. He is a recommended HIPEC expert in India by the American Society of Peritoneal Surface Malignancy (ASPSM).
The clinic, which is the first in India to offer HIPEC, is dedicated to providing the highest standards of care for patients undergoing major gastrointestinal and gynae-oncology surgeries.
Dr. Mehta is a board-certified oncology surgeon with over ten years of experience. He holds an MBBS degree and has completed fellowship training in gastrointestinal oncology and cytoreductive surgery (CRLC Val d’Aurelle, France), minimal access and gastrointestinal surgery (L’Hospital Saint Eloi, Centre Hospitaliere Universitaire, Montpellier, France), and laparoscopic and robotic colorectal surgery (St. Mary’s Hospital, South Korea).
Dr. Mehta is the recipient of the prestigious Rotary International Ambassador Scholarship (2009) and Outstanding Young Person Award from the Junior Chamber International (JCI). He is recognized as the first Indian surgeon to perform cytoreductive surgery and HIPEC using the advanced HIPEC system in the country as well as the first to perform the following surgeries: trans-anal full-thickness resection of benign tumours, villous adenomas, large polyps, and trans-anal total mesorectal excision.
Dr. Sanket Mehta’s HIPEC Clinic is modern and world-class. It is equipped with the most advanced technologies and state-of-the-art equipment used in traditional, minimally invasive, and robotic-guided surgical procedures. It is also staffed by friendly, accommodating, and knowledgeable staff members who are committed to providing the highest standards of medical care.
Dr. Sanket Mehta is an oncology (cancer) surgeon who pioneered the treatment of peritoneal malignancies with (CRS) cytoreductive surgeries and HIPEC (hyperthermic intra-peritoneal chemotherapy) in India. He is a recommended HIPEC expert by the American Society of Peritoneal Surface Malignancy (ASPSM), has over 10 years of experience, and specialises in cancers of the breast, esophagus, gallbladder, liver, pancreas, and stomach.